Departments of *Pathology

†Gynecologic Oncology, The University of MD Anderson Cancer Center, Houston, TX

Presented in part at the 110th Annual Meeting of The United States and Canadian Academy of Pathology, Los Angeles, CA, March 19-24, 2022.

Conflicts of Interest and Source of Funding: Supported by The University of Texas MD Anderson Cancer Center Division of Pathology and Laboratory Medicine Supplemental Research Fund. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Correspondence: Elizabeth D. Euscher, MD, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 85, Houston, TX 77030 (e-mail: [email protected]).